EMEA-002200-PIP02-19

Key facts

Active substance
  • Bempedoic acid
  • Ezetimibe
Therapeutic area
  • Cardiovascular diseases
  • Other
Decision number
P/0232/2019
PIP number
EMEA-002200-PIP02-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of mixed dyslipidaemia
Route(s) of administration
Oral use
Contact for public enquiries
Esperion Therapeutics, Inc.

E-mail: ahall@esperion.com
Tel.: +1 7346346816

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating